Explore 15 articles covering in-depth insights and practical guidance on ai for scientific discovery.
Running a single large-scale AI-driven drug discovery campaign costs $2–10 million in compute alone, while materials science screening runs $500K–$3 million. This guide details platform licensing fees, cloud compute pricing, data curation costs, and ROI timelines showing 3–7× returns when AI reduces R&D cycles from years to months.
Critical KPIs for AI-driven scientific discovery across materials science, drug development, climate modeling, and clean energy research, with 2024-2025 benchmark ranges and guidance on measuring real research acceleration.
AI foundation models like AlphaFold and GNoME can screen millions of candidate molecules or materials in hours versus months for traditional simulation, but accuracy gaps of 5–15% persist for novel chemistries. This comparison evaluates when to use ML-driven discovery versus physics-based methods across drug design, materials science, and climate modeling.
What's working, what isn't, and what's next, with the trade-offs made explicit. Focus on data quality, standards alignment, and how to avoid measurement theater.
A step-by-step rollout plan with milestones, owners, and metrics. Focus on KPIs that matter, benchmark ranges, and what 'good' looks like in practice.
A concrete implementation with numbers, lessons learned, and what to copy/avoid. Focus on implementation trade-offs, stakeholder incentives, and the hidden bottlenecks.
An in-depth analysis of the most dynamic subsegments within AI for scientific discovery, tracking where momentum is building, capital is flowing, and breakthroughs are emerging.
A comprehensive state-of-play assessment for AI for scientific discovery, evaluating current successes, persistent challenges, and the most promising near-term developments.
A practical primer: key concepts, the decision checklist, and the core economics. Focus on data quality, standards alignment, and how to avoid measurement theater.
Signals to watch, value pools, and how the landscape may shift over the next 12–24 months. Focus on data quality, standards alignment, and how to avoid measurement theater.
Myths vs. realities, backed by recent evidence and practitioner experience. Focus on KPIs that matter, benchmark ranges, and what 'good' looks like in practice.
Side-by-side analysis of common myths versus evidence-backed realities in AI for scientific discovery, helping practitioners distinguish credible claims from marketing noise.
Strategic analysis of value creation and capture in AI for scientific discovery, mapping where economic returns concentrate and which players are best positioned to benefit.
A forward-looking assessment of AI for scientific discovery trends in 2026, identifying the signals that matter, emerging winners, and red flags that practitioners should monitor.
A practitioner conversation: what surprised them, what failed, and what they'd do differently. Focus on implementation trade-offs, stakeholder incentives, and the hidden bottlenecks.